Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Current Deferred Revenue (2013 - 2024)

Xencor (XNCR) posted quarterly Current Deferred Revenue of $36.5 million for Q2 2024, up 361.67% year-over-year from $7.9 million in Q3 2023, and up 6.99% quarter-over-quarter from $34.1 million in Q1 2024.

Analysis

Xencor (XNCR) Current Deferred Revenue (2013 - 2024) Analysis & Trends

Xencor (XNCR) has reported Current Deferred Revenue for 12 consecutive years, with $36.5 million the latest figure, recorded in Q2 2024.

  • In Q2 2024, Current Deferred Revenue rose 361.67% year-over-year to $36.5 million; the TTM figure through Jun 2024 stood at $36.5 million (up 361.67% YoY), while the FY2022 annual figure was $30.3 million, down 18.71% from the prior year.
  • Current Deferred Revenue grew to $36.5 million in Q2 2024 per XNCR's latest filing, from $34.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $92.6 million in Q4 2020 and bottomed at $7.9 million in Q2 2023.
  • Historically, Current Deferred Revenue has averaged $37.0 million across 5 years, with a median of $35.3 million in 2022.
  • Annual changes were most pronounced in 2023 — Current Deferred Revenue sank 77.62% — and 2024, when it surged 361.67%.
  • Xencor's Current Deferred Revenue stood at $92.6 million in 2020, then slumped by 59.72% to $37.3 million in 2021, then declined by 18.71% to $30.3 million in 2022, then tumbled by 69.58% to $9.2 million in 2023, then surged by 295.49% to $36.5 million in 2024.
  • Business Quant data shows XNCR's Current Deferred Revenue at $36.5 million in Q2 2024, $34.1 million in Q1 2024, and $9.2 million in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Xencor 2.02 Bn 1.65 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 36.47 Mn
Mar 31, 2024 34.09 Mn
Sep 30, 2023 9.22 Mn
Jun 30, 2023 7.90 Mn
Mar 31, 2023 30.10 Mn
Dec 31, 2022 30.32 Mn
Sep 30, 2022 35.20 Mn
Jun 30, 2022 35.30 Mn
Mar 31, 2022 35.50 Mn
Dec 31, 2021 37.30 Mn
Sep 30, 2021 13.00 Mn
Jun 30, 2021 19.20 Mn
Mar 31, 2021 77.80 Mn
Dec 31, 2020 92.62 Mn
Sep 30, 2020 43.80 Mn
Jun 30, 2020 44.70 Mn
Mar 31, 2020 46.20 Mn
Dec 31, 2019 47.10 Mn
Sep 30, 2019 48.20 Mn
Jun 30, 2019 48.80 Mn